{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Antibody-drug conjugates comprising anti-prolactin receptor (PRLR) antibodies and methods of use thereof to kill PRLR-expressing cells", "item": "https://www.patentleaderboard.com/patent/10683354"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibody-drug conjugates comprising anti-prolactin receptor (PRLR) antibodies and methods of use thereof to kill PRLR-expressing cells

Antibody-drug conjugates comprising anti-prolactin receptor (PRLR) antibodies and methods of use thereof to kill PRLR-expressing cells

US Patent 10683354 · Granted Jun 16, 2020

Estimated economic value: $562,420,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-MSR1 antibodies and methods of use thereof2025
Non-human animals expressing humanized CD3 complex2025
Diels-Alder conjugation methods2025
Mouse having a humanized cluster of differentiation 47 gene2025
Biologically active molecules, conjugates thereof, and therapeutic uses2025
Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD2025
Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD2025
Maytansinoid derivatives, conjugates thereof, and methods of use2025
Multispecific antigen-binding molecules and uses thereof2025
Multispecific antigen-binding molecules and uses thereof2025
Multispecific antigen-binding molecules and uses thereof2025
Nucleic acid molecules encoding bispecific anti-BCMA x anti-CD3 antibodies2025